Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 95%
filed 2026-05-20
Item 1.01
The filing discloses entry into a material definitive agreement for the sale of The Pike Outlets (Long Beach, California) for approximately $50.0 million in gross proceeds ($46.0 million net). This is a disposition of a material asset by SITE Centers Corp. through its subsidiary, meeting the definition of ma_activity under Item 1.01. The transaction is material to investors as it represents a significant asset sale with expected closing by Q3 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-20
Item 5.02
Scott Hortenstine is being designated as Sabre's principal accounting officer and Vice President and Controller, effective July 1, 2026. This is a material executive appointment to a key financial reporting role. While the disclosure also notes that Jami Kindle will continue as principal accounting officer through June 30, 2026, the principal disclosed action is Hortenstine's appointment to this critical position, making this an exec_appointment event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-20
Item 8.01
This Item 8.01 disclosure reports the completion of a material asset sale: Lumen sold its Mass Markets fiber-to-the-home business across 11 states for $5.75 billion in gross cash proceeds (approximately $5.72 billion net). The company used proceeds to redeem substantial debt and repay credit facilities, representing a significant capital restructuring. Although the sale was initially reported in a February 2, 2026 Form 8-K, this filing provides updated pro forma financial information in connection with an S-4 registration statement, confirming the materiality and ongoing relevance of the transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 disclosure reports the results of Verra Mobility's 2026 annual meeting of stockholders held on May 19, 2026, including voting outcomes on four proposals: election of three Class II directors, approval of executive compensation on a non-binding basis, approval of annual say-on-pay frequency, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies (votes for, against, withheld, abstentions, and broker non-votes) for each proposal, which is the standard format for shareholder vote result disclosures under Item 5.07.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-05-20
Item 5.02
Patrick S. Pacious stepped down as President & CEO effective May 20, 2026, which is the principal disclosed action. While the filing also discloses the appointment of Dominic E. Dragisich as Interim CEO and compensatory arrangements for both executives, the salient event is the departure of the sitting CEO. The filing centers on the "leadership transition" triggered by Pacious's departure and includes detailed severance terms reflecting his executive status.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
Alkermes plc held its Annual Meeting on May 20, 2026, with shareholders voting on six matters: election of nine directors, advisory vote on named executive officer compensation, ratification of PricewaterhouseCoopers LLP as auditor, approval of amendments to the 2018 Stock Option and Incentive Plan (increasing authorized shares by 5,900,000), renewal of Board authority to allot and issue shares, and renewal of Board authority to disapply pre-emption rights. All matters received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 1.01
Sotera Health entered into Amendment No. 7 to its First Lien Credit Agreement on May 20, 2026, refinancing approximately $1.42 billion in term loans with a 0.25% reduction in interest rate spread and extending maturity to May 30, 2031.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-05-20
Item 1.01
Rehan Jaffer will be appointed to Six Flags' board of directors as a Class III director following the May 26, 2026 Annual Meeting, replacing departing director Arik Ruchim. The appointment is part of a Cooperation Agreement with H Partners, a significant long-term investor, and includes assignment to the Audit and Finance Committee, voting agreements, and standstill provisions affecting shareholder governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 filing discloses the results of the 2026 Annual Meeting of Shareholders held on May 19, 2026, including voting outcomes on three matters: election of nine directors (all elected with substantial majorities), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The disclosure of shareholder vote results is a core Item 5.07 event and is material to investors as it confirms board composition and auditor ratification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 disclosure presents the complete results of Con Edison's Annual Meeting of Stockholders held on May 18, 2026, including detailed voting tallies for the election of 11 directors, ratification of PricewaterhouseCoopers LLP as independent accountants, and an advisory vote on named executive officer compensation. The filing directly matches the shareholder_vote_results taxonomy definition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from DNOW Inc.'s Annual Meeting of Stockholders held on May 20, 2026. The filing presents detailed voting tallies for three matters: election of nine directors, ratification of KPMG LLP as independent auditors, and advisory approval of named executive officer compensation. All three matters were approved by stockholders with substantial majorities, making this a standard shareholder vote results disclosure that is material to investors as it confirms governance and audit arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes on four proposals: election of two Class III directors (Jean Franchi and Hany Massarany), advisory approval of named executive officer compensation, frequency of advisory votes on compensation, and ratification of KPMG LLP as independent auditor. All proposals passed with substantial majorities. This is material as it documents formal stockholder actions and governance outcomes.
View raw filing on EDGAR →
8-K
Exec departure
confidence 72%
filed 2026-05-20
Item 5.02
William E. Berry, Jr., Vice President and Chief Accounting Officer, is retiring effective September 1, 2026. While the filing also discloses Emily Baculik's appointment as his successor and compensatory arrangements for both executives, the principal disclosed action centers on Berry's departure from his officer role. The retirement of a named executive officer responsible for accounting oversight is material to investors assessing management continuity and financial reporting controls.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
Wesbanco's Board approved a new stock repurchase program authorizing up to 4.0 million shares, which is a material capital allocation decision affecting shareholder value and future earnings per share. While this is a routine corporate governance action, the authorization of a substantial share buyback program would affect a reasonable investor's assessment of the company's capital strategy and financial position, making it material despite not fitting neatly into more specific event categories.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-20
Item 5.07
This Item 5.07 filing discloses the results of Fold Holdings' Annual Meeting of Stockholders held on May 19, 2026, including voting outcomes for two proposals: election of two Class I directors (Bracebridge H. Young, Jr. and Andrew Hohns) and ratification of CBIZ CPAs P.C. as independent auditor. The tabulated vote counts for each proposal are the core disclosure, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder vote results from Lake Shore Bancorp's Annual Meeting of Shareholders held on May 20, 2026. The filing presents detailed vote tabulations for all four proposals: election of three Class Three directors, advisory vote on named executive officer compensation, frequency of advisory compensation votes, and ratification of the independent auditor. The vote counts and outcomes are explicitly stated, matching the definition of Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Motorola Solutions' 2026 Annual Meeting of Shareholders held on May 18, 2026. The filing reports voting outcomes for three proposals: election of eight directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with substantial majorities, making this a material disclosure of shareholder meeting outcomes.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-05-20
Item 5.02
Mark Weinswig resigned as Chief Financial Officer, effective June 15, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 7.01
Andrew Clipsham was appointed as Interim Chief Financial Officer, effective upon Weinswig's departure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 8.01
Eli Lilly completed a substantial $8.94 billion debt offering across eight series of notes with varying maturities and interest rates, including a contingent mandatory redemption provision tied to the Centessa Acquisition. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit neatly into the standard 8-K taxonomy (not an earnings release, M&A completion, impairment, or other specifically enumerated event type). The disclosure is material to investors as it reflects significant new debt obligations and conditional redemption terms dependent on an acquisition outcome.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 disclosure reports the results of Bausch & Lomb's Annual Meeting of Shareholders held on May 20, 2026, including voting outcomes on three proposals: election of ten directors, advisory vote on executive compensation, and appointment of PricewaterhouseCoopers LLP as independent auditor. The filing presents vote tallies (For, Against, Abstain, Broker Non-Votes) for each matter, which is the core content of shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 1.01
Williams Companies entered into two material credit agreements on May 19, 2026: a Second Amended and Restated Credit Agreement ($3.75 billion aggregate commitment with $500 million expansion option) and a 364-Day Credit Agreement ($1.0 billion aggregate commitment with $150 million expansion option). These agreements establish the company's primary liquidity facilities and contain financial covenants (debt-to-EBITDA ratio of 5.00:1.00).
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
The disclosure announces positive Phase 3 and Phase 2 clinical trial data presented at a major medical congress. While this represents material clinical progress for a biopharmaceutical company that could affect investor assessment of pipeline value and regulatory prospects, it does not fit the earnings_release category (which typically applies to financial results) nor any other more specific event type. The clinical data announcement is material but best classified as other_material given the taxonomy's focus on financial and corporate governance events.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-20
Item 2.02
The filing discloses a press release announcing first quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The explicit reference to "issued a press release announcing the first quarter 2026 results" and attachment as Exhibit 99.1 confirms this is a periodic earnings disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 7.01
This Item 7.01 Regulation FD Disclosure contains a Q&A addressing material business developments: Middle East disruption impacts, significant growth in customs brokerage driven by tariff refunds and regulatory complexity, AI/technology investments enhancing margins, and hyperscaler volume trends. While the disclosure is primarily forward-looking guidance and management commentary rather than a discrete event (M&A, restatement, departure, etc.), the substantive discussion of customs growth drivers, tariff refund activity, and technology initiatives would affect a reasonable investor's assessment of the company's near-term revenue and margin trajectory. This does not fit neatly into the more specific event categories but is material disclosure under Regulation FD.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-20
Item 1.01
Lumen and its subsidiary Qwest entered into a Support Agreement with noteholders to facilitate exchange offers for approximately $456 million of outstanding debt, involving the exchange of 6.5% Notes due 2056 and 6.75% Notes due 2057 for newly issued notes with extended expiration dates. This material capital structure modification affects investor assessment of the company's financial position and obligations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 3.02
The Company disclosed the sale of 30,481 Class D Common Shares for $840,000 under a continuous private placement offering of up to $2.165 billion in unregistered equity securities pursuant to Section 4(a)(2) and Regulation D Rule 506(c). This is a classic dilutive issuance of unregistered equity securities, and the forward-looking statements explicitly warn that "future sales or issuances of our Common Shares or other securities convertible into our Common Shares, or the perception thereof, could cause the value of our Common Shares to decline and could result in dilution."
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder voting results from Amgen's Annual Meeting held May 19, 2026, covering four matters: election of 12 directors, advisory vote on executive compensation, ratification of Ernst & Young LLP as independent auditors, and a stockholder proposal on board chairman independence. Item 5.07 explicitly requires disclosure of shareholder vote results, and these outcomes are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 85%
filed 2026-05-20
Item 8.01
The filing discloses three lawsuits challenging the proposed merger between Stellar Bancorp and Prosperity Bancshares, filed in New York Supreme Court in May 2026, plus demand letters from purported shareholders. Although the companies deny merit and made supplemental disclosures to avoid litigation delays, the disclosure of material litigation related to a pending merger transaction is a core 8-K Item 8.01 event that would affect a reasonable investor's assessment of transaction risk and timing.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
The filing discloses the appointment of Luke Wood to the board of directors following the board's approval to increase its size from twelve to thirteen members. While the section also mentions compensation under the Non-Employee Director Compensation Policy, the principal disclosed action is the appointment itself. The appointment of an experienced executive (former President of Beats by Dr. Dre and Apple VP) to the board is material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
AT&T held its 2026 Annual Meeting of Shareholders on May 14, 2026, with detailed voting results disclosed for director elections (10 nominees), board-sponsored proposals including auditor ratification, incentive plan approval, executive compensation advisory vote, and certificate amendments, as well as stockholder proposals on written consent rights and EEO-1 disclosure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-05-20
Item 5.02
Shareholders approved the 2026 Incentive Plan and an amendment and restatement of the Stock Purchase and Deferral Plan at AT&T's Annual Meeting on May 14, 2026, representing material changes to the company's executive and employee compensation structures.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Wells Fargo issued $6 billion in Medium-Term Notes (Series Y) across three tranches on May 20, 2026, with maturities in 2029 and 2032. This is a material debt issuance disclosed under Item 9.01 (Financial Statements and Exhibits) rather than a dedicated 8-K Item, making it a material financing event that does not fit neatly into the standard taxonomy categories. The filing documents the note forms and legal opinion, indicating a significant capital markets transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 75%
filed 2026-05-20
Item 8.01
The Item 8.01 disclosure centers on the Annual Meeting of Shareholders and announces that final voting results will be reported in a subsequent 8-K filing. While a quarterly dividend declaration is also mentioned, the substantive disclosure focuses on shareholder meeting events, which aligns with shareholder_vote_results. The dividend alone would be routine, but the shareholder meeting announcement elevates materiality.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
The filing discloses the appointment of John Hazlett as Chief Financial Officer effective May 20, 2026, with detailed background, qualifications, and employment terms including base salary of $216,000 and performance incentives. While the section also mentions the departure of the prior CFO John Ferry, the principal disclosed action centers on the new appointment and its terms, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
Southern First Bancshares held its annual meeting of shareholders on May 19, 2026, with voting results on three proposals: election of 16 directors, a non-binding say-on-pay resolution, and ratification of Elliott Davis, LLC as independent auditor. Detailed vote tallies for each matter are disclosed.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-20
Item 2.02
DUKE Robotics Corp. issued a press release on May 20, 2026 disclosing selected financial information for the three months ended March 31, 2026, providing quarterly financial performance data to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 90%
filed 2026-05-20
Item 8.01
SoftBank sold all 89,106,748 shares of Class A common stock to Tether International pursuant to a Sale and Purchase Agreement executed May 15, 2026 and completed May 19, 2026, with all Class B shares held by SoftBank simultaneously cancelled. This constitutes a material disposition and change of control affecting the company's ownership structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-20
Item 5.02
Jared Roscoe and Mr. Parekh resigned from the Company's board of directors and all applicable committees, effective May 19, 2026.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-05-20
Item 3.01
The Company notified NYSE on May 20, 2026 of non-compliance with continued listing rules: the resignation of Jared Roscoe from the board resulted in the audit committee falling below the minimum two independent directors required under NYSE Listed Company Manual Section 303A.07(a).
View raw filing on EDGAR →
8-K
Other material
confidence 70%
filed 2026-05-20
Item 8.01
All In FutureTech Alliance, Inc. (formerly Allied Gaming & Entertainment Inc.) completed a strategic review process and executed a corporate rebranding, including a name change effective May 15, 2026, and a new NASDAQ ticker symbol 'AIFA' effective May 19, 2026, with corresponding amendments to its Certificate of Incorporation and bylaws.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-05-20
Item 5.02
Michael Tarnok was appointed as a Class II director and Kevin Cameron (the CEO) was appointed as a Class III director; David Landskowsky resigned from the board. The board size increased from four to five members.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 8.01
VStock Transfer was terminated and Odyssey Transfer and Trust Company was appointed as the new exchange agent, transfer agent, and registrar, effective April 28, 2026.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-05-20
Item 3.01
The filing discloses that Singularity Future Technology Ltd. received a Nasdaq staff determination notice on November 19, 2025, for failure to maintain the $1 minimum bid price required under Nasdaq Listing Rule 5550(a)(2). The Company was initially granted a 180-day compliance period (until May 18, 2026) and subsequently granted a second 180-day compliance period (until November 16, 2026). The disclosure explicitly states that if the Company does not regain compliance by the Compliance Date, Nasdaq will provide written notification that the Company's securities are subject to delisting. This is a classic delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-20
Item 2.02
The filing discloses a press release announcing financial results for the three months ended March 31, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release, which is material to investors as it provides key financial performance metrics and operational updates.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 8.01
This disclosure announces the commencement of separate trading of Class A Ordinary Shares and Warrants previously bundled in Units, effective May 20, 2026. While this is a routine structural event for a SPAC, the ability to separately trade components affects the capital structure and liquidity profile available to investors, making it material to security holders. The event does not fit neatly into more specific categories (not M&A, not a dilutive issuance, not an impairment), so other_material is most appropriate.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-20
Item 2.02
The filing discloses a press release issued on May 20, 2026 regarding financial results for the quarter ended March 31, 2026, furnished under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release disclosure, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-05-20
Item 5.02
The disclosure centers on stock option awards granted to two named executives: Paul DiPerna (Chairman, President, CFO, Treasurer) received 11,218 options and Kevin Schmid (COO) received 4,674 options, with specified exercise price ($3.46), vesting schedule (one-third on May 14, 2027, then monthly thereafter), and 10-year expiration. This is a classic compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-05-20
The 8-K discloses a shareholder letter regarding "strategy overview and business update" filed under Item 8.01 (Other Events). Without access to the actual letter content (Exhibit 99.1), the materiality and specific event type cannot be definitively determined. The filing itself provides no substantive disclosure of the strategy or business update, making it impossible to classify into a more specific category. This is classified as other_material with moderate confidence, pending review of the attached exhibit.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder voting results from the May 19, 2026 Annual Meeting of Stockholders, covering three proposals: election of seven directors, ratification of Deloitte & Touche LLP as independent auditor, and approval of the Employee Stock Purchase Plan. The filing presents vote tallies (For, Against, Withheld, Abstain, Broker Non-Votes) for each proposal, which is the standard format for Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →